1 / 1

Comparative Analysis of Prognostic Value of AURKA and Ep-CAM in Metastasis-Free Survival

This study evaluates the independent prognostic capabilities of AURKA and Ep-CAM in predicting metastasis-free survival likelihood. Utilizing likelihood ratio statistics, we compared their contributions when integrated into existing models. Results indicate that AURKA significantly enhances prognostic information beyond traditional grading, particularly in the overall patient cohort and ER+/HER2- subgroups. Conversely, additional insights from Ep-CAM emerge only in the broader patient population, underscoring its contextual value in prognosis.

sanne
Télécharger la présentation

Comparative Analysis of Prognostic Value of AURKA and Ep-CAM in Metastasis-Free Survival

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Suppl. Fig. 1: Metastasis free survival likeliehood statistics as described by Prat et al., (2012). To compare the amount of independent prognostic information provided by Ep-CAM (A) and AURKA (B) we estimated the likelihood ratio statistic in a model that already included AURKA (A) or Ep-CAM (B). The model shows that AURKA provides significant additional information over grading in the cohort of all patients, as well as in the ER+/HER2- subgroups (B). Vice versa, Ep-CAM provides additional information over AURKA only in the cohort of all patients.

More Related